HPV vaccine shows promise for girls on Immune-Suppressing drugs

NCT ID NCT01687192

First seen May 25, 2026 · Last updated May 30, 2026 · Updated 2 times

Summary

This study looked at whether the HPV vaccine works in girls aged 9 to 17 who are taking medications that weaken their immune system, such as after an organ transplant or for diseases like lupus. The goal was to see if their bodies produce enough antibodies to protect against HPV. The results help doctors understand if these girls can get the same protection from the vaccine as healthy girls.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AP-HP, Hôpital Armand Trousseau

    Paris, 75571, France

  • AP-HP, Hôpital Necker-Enfants

    Paris, 75743, France

  • AP-HP, Hôpital Robert Debré

    Paris, 75019, France

  • CHU de Bordeaux, Hôpital Pellegrin-Enfants

    Bordeaux, 33076, France

  • CHU de Lille, Hôpital Jeanne de Flandres

    Lille, 59037, France

  • CHU de Montpellier, Hôpital Arnaud de Villeneuve

    Montpellier, 34295, France

  • CHU de Nantes, Hôpital Mère-Enfants

    Nantes, 44093, France

  • CHU de Toulouse, Hôpital des Enfants

    Toulouse, 31059, France

  • HCLyon, Hôpital Femme-mère-enfant

    Bron, 69677, France

Conditions

Explore the condition pages connected to this study.